Merck to Close Kendall Site

Merck (NYSE: MRK) announced plans to shutter its research site in Cambridge, MA’s Kendall Square neighborhood alongside seven other research facilities worldwide over the next two years. It will also phase out another eight manufacturing sites, as part a restructuring plan that follows its November 2009 merger with Schering-Plough. Some of the Kendall Square research operations will shift across the river to Merck’s facility in Boston’s Longwood Medical Area, a company spokesman told me. New Jersey-based Merck previously announced plans to cut 15 percent of its combined 100,000-person workforce, and the moves announced today will fall under that umbrella.

Trending on Xconomy

By posting a comment, you agree to our terms and conditions.

Comments are closed.